MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction

Table 1

Baseline characteristics of all study participants.

Variable	Control ()	STEMI ()	value
Age, years			0.689
Gender (, %)			0.315
Male	64 (64.00%)	134 (69.79%)
Female	36 (36.00%)	58 (30.21%)
Hypertension (, %)			0.346
No	66 (66.00%)	137 (71.35%)
Yes	34 (34.00%)	55 (28.65%)
Diabetes mellitus (, %)			0.284
No	82 (82.00%)	147 (76.56%)
Yes	18 (18.00%)	45 (23.44%)
Smoke (, %)			0.243
No	82 (82.00%)	146 (76.04%)
Yes	18 (18.00%)	46 (23.96%)
BMI, kg/m^2			<0.001
WBC, ×10^9/L			<0.001
Hemoglobin, g/L			0.011
hs-CRP, mg/L			<0.001
HDL-C, mmol/L			<0.001
LDL-C, mmol/L			0.67
Total cholesterol, mmol/L			0.013
Triglyceride, mmol/L			0.479
LDH, U/L			<0.001
CK, U/L			<0.001
CKMB, ng/mL			<0.001
hsTn T, ng/L			<0.001
NT-proBNP, pg/mL			<0.001
LP(a), mg/L			0.019

Abbreviations: STEMI: ST-Segment elevation myocardial infarction; WBC: white blood cell; hs-CRP: high-sensitivity C-reactive protein; HDL-C: high-density lipoprotein-cholesterol; LDL: low-density lipoprotein-cholesterol; LDH: lactate dehydrogenase; CK: creatine kinase; CKMB: creatine kinase MB; hsTn T: hypersensitive troponin T; NT-proBNP: N-terminal probrain natriuretic peptide; Lp(a): lipoprotein-a.